Could a mushroom compound turn back the clock on aging?

NCT ID NCT07750002

First seen Aug 06, 2026 · Last updated Aug 07, 2026 · Updated 1 time

Summary

This trial tests whether a daily supplement called NVTIA® ergothioneine can improve markers of healthy aging and skin health in healthy adults aged 35 to 55. Over 12 weeks, half the participants will take the supplement and half will take a placebo, with neither group knowing which they receive. Researchers will measure oxidative stress, skin elasticity, hydration, and inflammation to see if the supplement offers any benefits.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
NVTIA® ergothioneine, a branded dietary supplement
What this could lead to
If it works, this supplement could offer a simple way to support healthy aging and skin health in middle-aged adults.
What could go wrong
This is a small, early-stage trial, so results may not apply broadly. The supplement may not produce meaningful changes, and any benefits could be modest.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEALTHY AGING are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Dhaka Central International Medical College & Hospital

    RECRUITING

    Dhaka, Bangladesh

More trials for these conditions

Other studies related to the condition(s) this trial covers.